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Summary
Xeroderma pigmentosum (XP) complementation group
D is a heterogeneous group, containing patients with XP
alone, rare cases with both XP and Cockayne syndrome,
and patients with trichothiodystrophy (TTD). TTD is a
rare autosomal recessive multisystem disorder associ-
ated, in many patients, with a defect in nucleotide-
excision repair; but in contrast to XP patients, TTD
patients are not cancer prone. In most of the repair-
deficient TTD patients, the defect has been assigned to
the XPD gene. The XPD gene product is a subunit of
transcription factor TFIIH, which is involved in both
DNA repair and transcription. We have determined the
mutations and the pattern of inheritance of the XPD
alleles in the 11 cases identified in Italy so far, in which
the hair abnormalities diagnostic for TTD are associated
with different disease severity but similar cellular pho-
tosensitivity. We have identified eight causative muta-
tions, of which four have not been described before,
either in TTD or XP cases, supporting the hypothesis
that the mutations responsible for TTD are different
from those found in other pathological phenotypes.
Arg112his was the most common alteration in the Italian
patients, of whom five were homozygotes and two were
heterozygotes, for this mutation. The presence of a spe-
cifically mutated XPD allele, irrespective of its homo-
zygous, hemizygous, or heterozygous condition, was al-
ways associated with the same degree of cellular UV
hypersensitivity. Surprisingly, however, the severity of
the clinical symptoms did not correlate with the mag-
nitude of the DNA-repair defect. Themost severe clinical
features were found in patients who appear to be func-
tionally hemizygous for the mutated allele.
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Introduction
Trichothiodystrophy (TTD) is a rare autosomal recessive
disorder whose diagnostic hallmark is brittle hair. A
common feature of affected individuals is a decreased
amount of total sulfur content and of cystine and cysteic
acid in the hair, together with an abnormal distribution
of cystine-rich proteins in the cortex and hair cuticle.
Other clinical symptoms associated with TTD are ich-
thyosis, physical and mental retardation, and abnormal
facies (Itin and Pittelkow 1990). Although photosensi-
tivity has been reported in ∼20% of the cases and is
probably associated with a substantially higher propor-
tion, skin lesions and cutaneous tumors have never been
described in association with TTD. DNA-repair inves-
tigations have demonstrated that clinical photosensitiv-
ity is usually associated with cellular UV hypersensitivity.
In these cases, the cellular phenotype is similar to that
observed in the nucleotide-excision repair (NER)–
defective form of xeroderma pigmentosum (XP), the
very well-known autosomal recessive disorder charac-
terized by hypersensitivity to sunlight and by increased
incidence of skin cancer. Genetic studies using cell fusion
have enabled XP patients defective in NER to be clas-
sified into seven different complementation groups, des-
ignated “XP-A”–“XP-G” (for a review, see Bootsma et
al. 1998).
Despite the remarkable differences at the clinical level,
two of the genes with defects identified in XP—namely,
the XPB and XPD genes—have been found associated
with TTD (Stefanini et al. 1986, 1992, 1993a; Lehmann
et al. 1988; Vermeulen et al. 1994). One TTD patient
appeared to be defective in a new repair gene that has
been designated “TTDA” (Stefanini et al. 1993b).
Whereas XP-B is a very rare group with only three fam-
ilies identified, the XP-D defect has been found in a
substantial number of XP patients, in the majority of
repair-defective TTD patients, and in rare cases showing
the clinical features of Cockayne syndrome (CS) in ad-
dition to those of XP (Vermeulen et al. 1991; Broughton
et al. 1995). The apparent paradox of the presence of
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the same genetic defect associated with clinically distinct
disorders has been recently rationalized by the discovery
that the XPD protein, an ATP-dependent 5′r3′ helicase
(Sung et al. 1993), is a subunit of the transcription factor
TFIIH (Drapkin et al. 1994; Schaeffer et al. 1994), in-
volved in both NER and basal transcription. TFIIH is
a multifunctional protein complex containing at least
nine polypeptides, including the XPD and XPB gene
products (Hoeijmakers et al. 1996). It has been suggested
that clinical features diagnostic for XP could result from
mutations affecting only the NER function of TFIIH,
whereas those typical of TTD and CS could be explained
by a subtle impairment of the transcription function
(Bootsma and Hoeijmakers 1993; Vermeulen et al.
1994b). The mutations found in the patients, which are
obviously compatible with cellular viability, do not se-
riously impede basal transcription. They must impair
transcription only under certain conditions or in specific
cell compartments affecting, for example, only a limited
set of genes that critically demand optimal TFIIH
functioning.
Since the XP-D group is large and heterogeneous, the
definition of causative mutations in the patients repre-
sents a useful means to verify whether distinct patho-
logical phenotypes are caused by different alterations.
The XPD (originally ERCC2) gene was cloned because
of its ability to correct the UV sensitivity of a Chinese
hamster mutant belonging to rodent complementation
group 2 (Weber et al. 1988; Flejter et al. 1992). It is
highly conserved and encodes a protein with 50% amino
acid identity to Saccharomyces cerevisiae RAD3 and
Schizosaccharomyces pombe rad15 (Weber et al. 1990;
Murray et al. 1992) and with 83%, 98%, and 98%
identity to the Xiphophorus maculatus, mouse, and Chi-
nese hamster homologues, respectively (Kirchner et al.
1994; Della Coletta et al. 1995; de Boer et al. 1998).
To date, analysis of mutations in the XPD gene has been
performed in 21 XP cases (Frederick et al. 1994; Tak-
ayama et al. 1995; Kobayashi et al. 1997; Taylor et al.
1997), eleven TTD patients (Broughton et al. 1994; Tak-
ayama et al. 1996, 1997; Taylor et al. 1997) and in 2
XP/CS patients (Broughton et al. 1995; Takayama et al.
1995). These studies have identified several altera-
tions—mainly point mutations resulting in single amino
acid substitutions in the carboxy-terminal portion of the
protein—most of which are specifically associated with
a unique pathological phenotype (XP, TTD, or XP/CS).
The recent demonstration that the few mutations ob-
served in both XP and TTD behave as null alleles further
supports the hypothesis that the site of mutation deter-
mines the clinical features (Taylor et al. 1997). However,
despite the significant progress in our understanding of
the complex genotype-phenotype relationships associ-
ated with the XPD gene, several unanswered questions
remain, concerning the basis of the cellular heterogeneity
of the repair defect and the correlation between clinical
features, repair defect, and molecular alteration in TTD.
Since our first report in 1986, we have further ex-
tended DNA-repair investigations of TTD, and we thus
far have identified 11 cases in Italy in whom photosen-
sitivity results from a defect in the XPD gene. The cel-
lular response to UV in all these cases is drastically
altered, resulting in a similar degree of UV hyper-
sensitivity; in contrast, striking differences in both the
progression and the severity of the disease became evi-
dent among the patients over the years.
To clarify the basis of this clinical heterogeneity and
of its puzzling relationship with the repair defect, we
have performed a molecular analysis in the Italian fam-
ilies with TTD-affected members. We have identified the
potentially causative mutations in the XPD gene of the
patients and have determined the linkage relationship
between different mutations, by analysis in the parents.
Besides providing additional data on primary alterations
responsible for the TTD pathological phenotype, this
study sheds new light on the different effect that mutated
XPD proteins might have on repair and transcription.
Subjects, Material, and Methods
Case Reports
The study was performed on 11 Italian patients af-
fected by TTD; the diagnosis in all cases was confirmed
by analysis of the hair. Pili torti, trichoschisis, and tri-
chorrhexis nodosa were observed. Polarization micros-
copy revealed the typical appearance of alternating light
and dark bands, giving a “tiger tail” pattern. Photosen-
sitivity was reported in all patients, in association with
the other symptoms typical of TTD—namely, ichthyosis,
delayed physical and mental development, nail dyspla-
sia, a face characterized by a receding chin, small nose,
and large ears, and microcephaly. Detailed clinical and
DNA-repair data on several of these cases have been
published, and related literature references are reported
in table 1. The seven patients still alive are ages 4–30
years; the four cases that died during early infancy
showed severe physical and mental retardation and fre-
quently suffered from respiratory infections. The oldest
patients (TTD1PV, TTD2PV, and TTD3PV) developed
freckles during childhood, thus far without any pro-
gression to malignancy, and they have short stature (140
cm), began to menstruate at age 18 years, and no longer
are prone to infections, although they suffered moderate
infections during early childhood. TTD1PV suffers from
severe myopia, but she is able to write and to read.
Mental development in the sisters TTD2PV and
TTD3PV is at the preschool level. TTD6PV died at age
3.5 years, of pneumonia. Her physical and mental de-
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Table 1
Italian Patients Affected by TTD
PATIENTa
(SEX)
AGE AT
(years) IMPAIRMENT
REFERENCE(S)Diagnosis Presentb Physicalc Mentald
TTD1PV (F) 18 30 Moderate Moderate Stefanini et al. (1986, 1992)
TTD2PV (F) 4 20 Moderate Moderate Stefanini et al. (1986, 1992)
TTD3PV (F) 3 21 Moderate Moderate Stefanini et al. (1986, 1992, 1993a)
TTD4PV (F) 1 (4) Severe Severe Stefanini et al. (1986, 1992)
TTD6PV (F) (At birth) (3.5) Severe Severe Marinoni et al. (1991), Stefanini et al. (1992, 1993a)
TTD7PV (F) 2 (4) Severe Severe Stefanini et al. (1992, 1993a)
TTD8PV (M) 1 9 Moderate Moderate Stefanini et al. (1992, 1993a), Battistella and Peserico (1996)
TTD10PV (F) 12 18 Moderate Moderate Peserico et al. (1992), Stefanini et al. (1993a)
TTD11PV (M) 4 11 Severe Severe Present study
TTD12PV (M) .75 (2) Severe Severe Present study
TTD15PV (M) (At birth) 3.5 Severe Severe Present study
a TTD2PV and TTD3PV are sisters, and TTD12PV and TTD15PV are brothers.
b Ages in parentheses are age at death.
c Moderate  survival beyond early childhood, delayed puberty, and short stature; Severe death during childhood and/or failure
to thrive/dystrophy.
d Moderate  mental development at either preschool level or (in the case of TTD1PV) primary-school level, axial hypotonia,
and reduced motor coordination; Severe  very poor mental and motor performances and speech.
velopment was severely compromised. She was unable
to stand up and to manipulate.
TTD11PV, born in 1987, shows ichthyosis, peculiar
face, brittle hair, and spontaneous nystagmus. At 3 mo
of age he experienced sunburn after very short exposure
to sunlight. On clinical examination at age 4 years, the
skin appeared ichthyotic, with freckles in the photoex-
posed area; the teeth were dystrophic, and the degree of
growth and mental retardation was severe. At age 4.5
years, he developed chronic diarrhea; malabsorption; at-
rophy of villi, on jejunal biopsy, with multiple food in-
tolerance (but not celiac disease) requiring prolonged
parenteral and enteral nutrition; and further regression
of the mental and motor capabilities. Subsequently, he
experienced repeated and severe infectious illnesses,
mainly of the gastrointestinal and respiratory tract. At
age 11 years, he is now severely dystrophic (weight 11
kg, height 112 cm) and is unable to stand and speak.
TTD12PV, born in 1992, was the second child of
healthy unrelated parents. He was referred to us when
he was 9 mo of age; he had brittle hair, ichthyosis, nail
dysplasia, peculiar face, and severely retarded physical
and mental development. He underwent several episodes
of respiratory illness and died at age 2 years.
TTD15PV is a brother of TTD12PV, born in 1994.
TTD was diagnosed at birth. He underwent several ep-
isodes of respiratory illness and, at age 2 years, he
showed severe growth retardation (weight 8,900 g), de-
layed motor and mental development, neutropenia, and
strabismus.
Cells and Culture Conditions
Primary fibroblast cultures were established from the
skin of the 11 TTD patients and their parents. Lym-
phoblastoid cell lines were established by Epstein-
Barr–virus transformation of peripheral blood lympho-
cytes from the parents of TTD4PV, from whom biopsies
were not available. Fibroblasts were routinely grown in
Ham’s F-10 medium (Gibco) supplemented with 5%
newborn calf serum (Irvine Scientific) and 10% FCS (Ir-
vine Scientific) and were subcultured by trypsinization.
Lymphoblastoid cell lines were cultured in RPMI 1640
medium (Hyclone) supplemented with 15% FCS in a
3% CO2 atmosphere. Fibroblasts from three healthy do-
nors (C3PV, B119, and CF) and from two XP patients
previously assigned to group D were used as reference
strains in the study.
DNA-Repair Investigations
The response to UV irradiation was analyzed by mea-
surement of cell survival and by unscheduled DNA syn-
thesis (UDS). Definition of the genetic defect responsible
for UV hypersensitivity was accomplished by classic
complementation assays. Procedures for cell survival,
UDS, and genetic analysis are those routinely used in
our laboratory and have been described elsewhere (Ste-
fanini et al. 1992, 1993a).
Molecular Analysis of the XPD Gene
RNA and genomic DNA were simultaneously ex-
tracted, by a cesium chloride–gradient centrifugation
procedure, from samples of fibroblasts or72# 10
lymphoblastoid cells (in the case of TTD4PV’s81# 10
parents), and were resuspended in 1 ml of guanidinium
thiocyanate buffer (4 M guanidinium thiocyanate, 3 M
Na acetate pH 6).
RNA was reverse transcribed into cDNA, with Mo-
Table 2
PCR Amplification Primers for the XPD Gene
AMPLIFIED REGIONa
FRAGMENT SIZEb
(bp)
5′ PRIMER 3′ PRIMER
Code Sequence Code Sequence
51 to 690 640 AL32 5′-GACCCCGCTGCACAGTCCGG-3′ AL33 5′-CACATTGGCATGCAGGATTG-3′
442 to 1085 644 BB14 5′-ACACCCCTGCGCTTTGGGAAGGAC-3′ BB8 5′-AGCCGCCTCAGGAAGCCCAGGAA-3′
1025 to 1665 641 BB9 5′-AGGAGGCAGTGCCTGGCTCCATCC-3′ E23 5′-AGCGGACATCTCCAGCAGGAGGTTCC-3′
1433 to 2397 965 BB3 5′-AGTCTGTCATCATCACATCTGGGACACTGT-3′ BB16 5′-GTCACCAGGAACCGTTTATGCCCCACCCG-3′
2119 to 2397 279 AL37 5′-GACAAGCGGTTTGCCCGT-3′ BB16 5′-GTCACCAGGAACCGTTTATGCCCCACCCG-3′
242 to 114 659 U1 5′-GGCAGGCGCAGGAGGACCAA-3′ L2 5′-GAAGTAGACCAGGAGCCCGT-3′
267 to 419 357 U2 5′-TCCGCTGGAGGTGACCAAAC-3′ L5 5′-TCAGGGTGAATACACAAGTT-3′
402 to 610 3767 BB12 5′-TCTGAGCTCCCGCAAAAACTTGTGTATTCA-3′ BB13 5′-CCAGGTTGTAGATGCCAGCGGG-3′
1858 to 2197 855 AL36 5′-GCCATCCTGCTGTCAGTG-3′ BB19 5′-TGAGGTTGGCATCTGTGAG-3′
2128 to 2397 756 BB21 5′-TTTGCCCGTGGGGACAAGCGGGGGA-3′ BB16 5′-GTCACCAGGAACCGTTTATGCCCCACCCG-3′
2128 to 178 941 BB21 5′-TTTGCCCGTGGGGACAAGCGGGGGA-3′ L4 5′-TGGGCTGGTGGGGTGAGAGGGGGTC-3′
a Numbers correspond to position on cDNA (Weber et al. 1990). For primers U1 and L4, the numbers 242 and 178 correspond, respectively, to the position on the
genomic 5′- and 3′-flanking sequences of the XPD transcribed region (GenBank accession L47234).,
b The first five fragments (underlined) were amplified from cDNA; the others were amplified from genomic DNA.
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loney murine leukemia virus reverse transcriptase (M-
MLV RT). In brief, 2 mg of RNA in a total volume of
10 ml were heated to 90C for 2 min, and then 30 ml of
a mix containing 1 # first-strand cDNA buffer (Gibco
BRL), 10 mM DTT, 1 mM of each dNTP, 100 ng of
oligo(dT)15 (Promega), and 200 U of M-MLV RT
(Gibco BRL) were added. After incubation at 37C for
1 h, the samples were heated to 95C for 5 min, were
increased to a volume of 100 ml by the addition of water,
and were stored at 20C. PCR-amplification condi-
tions were as follows: 10–50 of ml cDNA were used in
100-ml reactions containing 1 # Gene Amp buffer II
(Perkin-Elmer), 2 mM MgCl2, 0.2 mM of each dNTP,
100 pmol of each of the required primers (table 2), and
2 U of AmpliTaq (Perkin-Elmer). Amplification was per-
formed with 31 cycles each of 94C for 1 min, 65C for
2 min, and 70C for 4 min.
Genomic DNA amplification was performed on 1 mg
of DNA samples, with the primers listed in table 2. The
PCR conditions for the primer pairs AL36 and BB19,
BB21 and BB16, and BB21 and BB16 were as described
for cDNA. Amplification with the primer pairs U1 and
L2 and U2 and L5 was performed by use of AmpliTaq
Gold (Perkin-Elmer) and the following cycling param-
eters: 1 cycle of 95C for 12 min and then 40 cycles
each of 95C for 1 min and 65C for 10 min. For the
primer pair BB12 and BB13, the XL PCR Kit (Perkin-
Elmer) was used; the reaction mix contained 1 # XL
buffer, 1 mM Mg(OAc)2, 0.2 mM of each dNTP, 200
pmol of each of the primers, and 6 U of rTth DNA
polymerase XL. Amplification was performed by use of
38 cycles each of 94C for 1 min and 68C for 10 min.
PCR products were separated and excised from 1.5%
low-melting-point agarose gels and then were purified
by means of the Wizard PCR Preps Purification System
(Promega). Products for the primer pair AL37 and BB16
were separated and excised from 4% NuSieve agarose
gels.
The products from the primer pair BB9 and E23 were
cloned into the pMOSBlue T-vector by use of the
pMOSBlue T-vector kit (Amersham), and double-
stranded plasmid DNA was prepared by a conventional
mini-alkaline–lysis method.
Purified PCR fragments and plasmid DNA with ap-
propriate inserts were directly sequenced by means of
the ThermoSequenase cycle sequencing kit (Amersham),
according to the three dNTPs internal-label protocol and
the manufacturer’s instructions.
Results
DNA-repair investigations in the Italian patients with
clinical diagnoses of TTD have allowed us, thus far, to
identify 11 cases from nine families in whom the cellular
response to UV irradiation is clearly altered. Fibroblast
strains from these patients show both a drastic reduction
in the capacity to perform DNA-repair synthesis (with
UDS levels that are 8%–28% of normal) and an in-
creased sensitivity to the killing effects of UV light (fig.
1). An altered response to UV irradiation, in patients
TTD1PV, TTD2PV, TTD3PV, TTD4PV, TTD6PV,
TTD7PV, TTD8PV, TTD9PV, and TTD10PV, has been
described elsewhere (see refs. cited in table 1), and the
values in the present series of experiments are similar to
those reported earlier. Genetic analysis performed by
complementation studies indicated that the repair alter-
ation in all the patients is due to the presence of a mu-
tation in the XPD gene. Despite the similar degree of
photosensitivity at the cellular level, the marked differ-
ences at the clinical level that were observed among pa-
tients over the years (see table 1) prompted us to identify
the molecular alterations responsible for the patholog-
ical phenotypes. The nucleotide sequence of the coding
region of the XPD gene was analyzed by reverse-tran-
scription PCR followed by direct sequencing (nucleo-
tides 79–2361 in the report by Weber et al. [1990]). The
mutations found in the patients were investigated in the
parents by sequencing of the relevant cDNA fragments.
The results are described below and are summarized in
figure 2.
Patients TTD1PV, TTD2PV, TTD3PV, TTD8PV, and
TTD10PV
Complete sequencing of the XPD cDNA in the five
patients TTD1PV, TTD2PV, TTD3PV, TTD8PV, and
TTD10PV (who were from four families,TTD2PV and
TTD3PV being sisters) revealed the presence, in the
whole of the amplified population, of both a silent ArC
transversion at position 546 and a GrA transition at
position 413, resulting in an arg112his substitution. All
the parents were heterozygous for the G413A transition,
confirming that the five patients are homozygotes. All
the fathers were heterozygous, and the mothers homo-
zygous, for the silent mutation at position 546. There-
fore the A546C change in the fathers is present on the
XPD allele carrying the G413A mutation, whereas in
the mothers the silent mutation is present on both XPD
alleles.
Patient TTD6PV
Patient TTD6PV showed, in the whole of the ampli-
fied cDNA population, both the silent transversion
A546C and, at position 2096, an ArG transition re-
sulting in an asp673gly substitution. The patient’s father
was heterozygous for the asp673gly change (fig. 3A). In
contrast, no mutation was identified in the cDNA of the
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Figure 1 Response to UV irradiation in fibroblast strains from repair-defective TTD patients (“TTD” prefix has been omitted). A, Repair
synthesis after 20 J/m2 in all the cases identified in Italy thus far (gray-shaded cols.) and in the British patients 2GL and 1BEL (diagonally
hatched cols.). The mean number of autoradiographic grains per nucleus is expressed as percentage of the level observed in normal cells analyzed
in parallel; the reported values are the mean of at least three independent experiments. B, Survival, after UV irradiation, of nondividing cells
from Italian TTD patients (symbols), normal subjects (gray-shaded area), and XP patients belonging to the D group (broken line). An altered
response to UV irradiation in patients TTD1PV–TTD4PV, TTD6PV–TTD10PV, TTD2GL, and TTD1BEL has been described in previous reports
(Stefanini et al. 1986, 1992, 1993a); the values in the current series of experiments are similar to those reported in those earlier studies.
mother, suggesting the occurrence of an unexpressed al-
lele. The lack of expression of the maternal XPD allele
was confirmed by the observation that, in the genomic
DNA, the patient was heterozygous for the A2096G
change. The patient is therefore functionally hemizy-
gous. Previous analysis by Southern blotting did not re-
veal any large deletion or rearrangement involving the
XPD gene, either in the patient or in her mother (Mon-
dello et al. 1994). We therefore searched for a causative
mutation in the 5′- and 3′-flanking sequences of the unex-
pressed allele, by amplifying these regions in the genomic
DNA of the XPD gene in the patient. We used primers
starting 242 and 178 nucleotides upstream and down-
stream, respectively, of the transcribed region. No mu-
tation was revealed by sequencing of either region, in-
dicating that (i) the expression failure is not caused by
transcript instability due to alterations in the polyadenyl-
ation signal in the genomic 3′-flanking region and (ii)
the expression of the XPD gene appears to require some
transcriptional control elements in addition to those con-
tained in the genomic 5′-flanking region—namely, the
classic promoter elements (TATA, CAAT, and GC boxes)
and a pyrimidine-rich region postulated to play an im-
portant role in the expression of the gene (Weber et al.
1990).
Patients TTD12PV and TTD15PV
The two affected brothers, TTD12PV and TTD15PV,
were compound heterozygotes. A GrA transition at po-
sition 854, resulting in a cys259tyr substitution, was
maternally inherited, and a CrT transition at position
2242, resulting in an arg722trp substitution, was pa-
ternally inherited (fig. 3B). In addition, the father was
heterozygous for a silent CrT transition at 2211. This
alteration must be on the normal XPD allele of the fa-
ther, because it was not present in the patients.
Patient TTD4PV
Complete sequencing of the XPD cDNA in patient
TTD4PV revealed that the patient was heterozygous for
three changes: a GrA transition (maternally inherited)
Figure 2 Mutations found in the XPD alleles of 11 Italian TTD patients from nine families. Causative mutations detected in XPD cDNA,
as well as resulting protein alterations, are within the ovals.
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Figure 3 Mutations in the XPD cDNA of patients TTD4PV, TTD6PV, TTD11PV, TTD12PV, and TTD15PV. A–C, Autoradiographs of
sequencing gels, showing A2096G transition in the family of TTD6PV (A), G854A and C2242T transitions in the family of the brothers
TTD12PV and TTD15PV (B), and the three-base deletion in allele 2 of TTD4PV (C). D, Agarose gel electrophoresis of PCR amplification
products of 5′ region of XPD cDNA in the family of TTD11PV.
at position 413, resulting in an arg112his substitution;
a silent ArC transversion at position 546; and a three-
base deletion (inherited fro the father), resulting in loss
of thr482. The latter was confirmed by the sequencing
of individual clones and could have arisen from the de-
letion of triplet 1521–1523, triplet 1522–1524, or triplet
1523–1525 (fig. 3C).
Patient TTD11PV
Amplification of the 5′ region of the XPD cDNA from
patient TTD11PV produced both a fragment of normal
size and a shorter fragment (fig. 3D). Analysis of the
normal-size fragment revealed a GrA transition (ma-
1044 Am. J. Hum. Genet. 63:1036–1048, 1998
ternally inherited) at position 413. Sequencing of the
short fragment that was present in both the patient and
his father demonstrated that it was missing 117 bases
corresponding to exon 6. Analysis of the genomic DNA
region including exons 5–7 identified a GrA transition
in the last base of intron 5. Both the patient and his
father were heterozygous for this mutation, which would
destroy the splice acceptor site for intron 5. The loss of
39 amino acids encoded by exon 6 is likely to destroy
the activity of the protein completely. (The silent ArC
transversion at position 546 was present in both parents,
in the heterozygous state, but was not present in the
patient. It must therefore be present on the normal XPD
allele of the parents.)
Patient TTD7PV
Five changes were identified in the XPD cDNA of
patient TTD7PV (fig. 2). Direct sequencing of the nu-
cleotide fragment 1433–2397 revealed the occurrence of
both a paternally inherited heterozygous CrG trans-
version at position 1459 and a 45-bp deletion of nucle-
otides 2224–2268. This is consistent with previous re-
ports, in which these two mutations were always found
associated on the same allele (Takayama et al. 1995,
1996; Taylor et al. 1997). The fragment containing the
deletion could be separated from the other allele by sep-
aration of the PCR products amplified from nucleotides
2119–2397, on a 4% NuSieve agarose gel. The normal-
size fragment contained a maternally inherited CrT
transition at position 2242, resulting in an arg722trp
change. Genomic DNA analysis in the members of
TTD7PV’s family demonstrated that the patient and her
father were heterozygous for a CrG transversion cor-
responding to position 2228 of the cDNA. This muta-
tion creates a new splice-donor site for intron 22, at
position 2223/4, resulting in both deletion of the cDNA
region 2224–2268 and loss of amino acids 716–730. In
addition, two silent changes were observed. The patient
and her father were homozygous, and her mother was
heterozygous, for the A546C transversion, and the pa-
tient and her mother were heterozygous for a CrT tran-
sition at position 2211. In conclusion, patient TTD7PV
had a maternally inherited C2242T transition associated
with the silent mutations A546C and C2211T and had
a paternally inherited XPD allele carrying both the silent
change A546C and the C1459G and C2228G trans-
versions.
Discussion
In Italy, 11 patients from nine families have been iden-
tified in whom the hair abnormalities diagnostic for TTD
are associated with photosensitivity and the other symp-
toms typical of the disease. In all these patients, clinical
photosensitivity was associated with an altered cellular
response to UV light, characterized by low levels of
DNA-repair synthesis and survival. As indicated by com-
plementation analysis, this cellular phenotype was due
to defect(s) in the XPD gene. As summarized in figure
2, in total we detected two silent mutations, an unex-
pressed allele, and eight potentially causative mutations,
four of which have not been described elsewhere. The
silent A546C and C2211T changes are polymorphisms
frequently observed both in the normal population and
in affected individuals (Broughton et al. 1996; present
study).
The most frequently observed mutation responsible
for the pathological phenotype in the Italian TTD pa-
tients was G413A, resulting in arg112his. Five pa-
tients (TTD1PV, TTD2PV, TTD3PV, TTD8PV, and
TTD10PV) were homozygous, and two patients
(TTD4PV and TTD11PV) were heterozygous, for this
mutation. All the homozygotes for the G413A mutation
were also homozygotes for the A546C silent change.
These results strengthen the hypothesis that there was a
common ancestor, which was suggested elsewhere by
consanguinity studies, of the families of patients
TTD1PV, TTD2PV, TTD3PV, and TTD4PV (Nuzzo et
al. 1990). The maternal allele of TTD11PV, in which
the G413A transition was not linked to the A546C poly-
morphism, is likely to have a different origin.
New Mutations
We have detected the following several mutations, not
described elsewhere, that are expected to compromise
the function of the protein severely: (1) Thr482, which
is deleted in TTD4PV, is located in a sequence of nine
amino acids that are predicted to be in alpha-helical
conformation (L. Brocchieri, personal communication)
by the PHD secondary-structure–prediction protocol
(Rost and Sander 1993, 1994; Rost et al. 1994). (2) In
patient TTD11PV, a GrA transition in the last base of
intron 5, resulting in the deletion of the whole of exon
6, is likely to abolish function completely. (3) The
asp673gly change, which is found in patient TTD6PV,
alters a residue that is conserved in five homologues
(human, rodent, fish, and the yeasts Saccharomyces cer-
evisiae and S. pombe); this mutation must be responsible
for the pathological phenotype, because the maternal
allele was not expressed in patient TTD6PV’s cells. (4)
The cys259tyr change, found in patients TTD12PV and
TTD15PV, alters a residue that is located in RNA hel-
icase domain V and that is conserved in three of the
homologues (human, rodent, and fish) but not in the
yeasts S. cerevisiae and S. pombe (where it is replaced
by alanine). This mutation is likely to interfere with the
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Figure 4 Mutations in the XPD protein in TTD, XP, and XP/CS patients. The diagram shows the XPD protein, with the helicase domains
(blackened boxes) and the putative nuclear-location signal (gray-shaded box). The amino acid changes resulting from the mutations found in
the different pathological phenotypes are shown boxed, with the change shown as either white on black (for TTD) or black on white (for XP
[dotted border] and for XP/CS [unbroken border]). The changes responsible for the pathological phenotype, those resulting in deletions likely
to affect cellular viability, and mutations described, by Taylor et al. (1997), as being lethal are indicated by unbroken, dashed, and dotted
arrows, respectively. Numbers “1” and “2” after the patient code denote the different alleles. The mutation leu461val and the deletion 716–730
have always been found associated in a single haplotype.
function of the XPD protein at least as drastically as the
arg722trp does. Both the severity of the clinical symp-
toms and the DNA-repair defect in both brothers are
similar to those reported for three other TTD patients
(TTD1BEL, TTD1VI, and TTD7PV) in whom the allele
carrying this mutation is likely to be the one relevant
for the pathological phenotype (Taylor et al. 1997).
Relationship between Mutation and Repair Deficiency
All the mutations found in XP patients in the XP-D
group (fig. 4) appear to result in a similar degree of
impairment in the cellular response to UV irradiation
(Taylor et al. 1997). In contrast, a wide range of sen-
sitivity to the lethal effects of UV light is observed in
TTD (Lehmann et al. 1988; Stefanini et al. 1992, 1993a).
The Italian patients and some of the non-Italian cases
(e.g., patients TTD2GL and TTD1BEL in fig. 1) show
a drastic reduction in UDS levels, with a cellular sensi-
tivity, to UV, that is similar to or even greater than that
in XP-D patients (fig. 1). Other non-Italian TTD patients
are characterized by a lower reduction in UDS level, with
survival levels significantly affected only at high UV
doses (Stefanini et al. 1992, 1993a). These different de-
grees of impairment in the cellular responses to UV in
TTD appear to be related to specific mutations. Com-
parison of figures 1 and 4 shows that a remarkable UV
sensitivity is associated with the arg112his substitution,
the change most frequently found in TTD, as well as
with both the asp673gly change, the only expressed al-
lele in patient TTD6PV, and (somewhat less marked) the
arg722trp change, the relevant alterations in patients
TTD7PV, TTD1BEL, TTDIVI and, likely, in the brothers
TTD12PV and TTD15PV. Mild UV sensitivity is asso-
ciated with mutations resulting either in a change of
arg658 or in the loss of the final portion of the XPD
protein. Intriguingly, as already mentioned, the repair
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defect in TTD never results in an increased incidence of
tumors or even in the severe skin alterations typically
reported for XP cases. It has been suggested that the
clinical features of XP are due to mutations affecting
only the repair function of the XPD protein, whereas
the TTD phenotype is the result of mutations that also
compromise the transcription activity of TFIIH, perhaps
interfering with tissue-specific transcription or the tran-
scription of a specific set of genes (Bootsma and Hoeij-
makers 1993). Since this model does not obviously ex-
plain the lack of cutaneous lesions and skin cancers in
TTD, it is necessary to postulate that the transcriptional
defect in some way suppresses the development of an
NER defect into sunlight-induced skin abnormalities.
Relation between Mutation and Clinical Severity
Perhaps surprisingly, the clinical features of the TTD
patients do not correlate with their repair deficiencies.
At the cellular level, all the Italian patients have a severe
DNA-repair defect, resulting in UV hypersensitivity sim-
ilar to (in the case of patients TTD7PV, TTD12PV,
TTD13PV, TTD14PV, and TTD15PV) or even greater
than that in XP-D cells. In contrast, there are substantial
clinical differences in the severity of their mental and
growth retardation, in their proneness to infections, and
in their ages at death (see case reports and table 1). The
less-compromised pathological phenotype is present in
patients homozygous for the arg112his change, who
have the most severe repair defect. They are all alive, at
ages 9–30 years, and they show relatively moderate psy-
chomotor retardation and no increased proneness to in-
fections. They are able to stand up, to manipulate things,
and to have social relations. If we assume that the fea-
tures of TTD do indeed result from transcriptional ab-
normalities (see above), this suggests that, although the
arg112his change has the most drastic effect on the re-
pair activity of TFIIH, this is not the case for its tran-
scriptional activity.
In contrast, it is striking that three patients, who are
compound heterozygotes for the arg112his change (in
the case of TTD4PV and TTD11PV, both of whom are
described in the present study) and TTD2GL (described
in Lehmann et al. 1988; Tolmie et al. 1994), are more
severely affected at the clinical level than are the
arg112his homozygotes. Both patient TTD4PV and pa-
tient TTD2GL (Tolmie et al. 1994) showed little mental
and physical development, had recurrent infections, and
died in early infancy. At age 11 years patient TTD11PV
is severely dystrophic, unable to speak or stand up, and
experiences repeated and severe infectious illnesses. The
second allele in these three patients is likely to be totally
nonfunctional. We showed this directly for patient
TTD2GL (Taylor et al. 1997); in TTD11PV, the paternal
allele contains a large deletion; and, in patient TTD4PV,
a critical threonine residue is deleted in the paternal al-
lele. These observations allow us to speculate that the
main determinant of the severity of the clinical features
might be the effective XPD-gene dosage. Results of ex-
amination of the mutations identified in other severely
affected patients (fig. 4) are consistent with this hypoth-
esis. In most of these patients, one of the alleles is com-
pletely nonfunctional. In the present study, this is clearly
the case for patient TTD6PV (in whom only one allele
expressed) and patient TTD7PV (in whom the paternally
inherited allele has been shown, by Taylor et al. [1997],
to be lethal), as well as for those patients with the
arg112his change, discussed above. Likewise, in the se-
verely affected patients TTD1BEL and TTD1VI, de-
scribed elsewhere (Broughton et al. 1994; Takayama et
al. 1996), one allele was shown to be nonfunctional
(Taylor et al. 1997). This group of compound hetero-
zygotes is therefore functionally hemizygous. Conse-
quently, not only will their TFIIH contain a partially
functionally mutated XPD subunit, but it also will be
present at only half the normal amount. This may well
result in a more severe impairment of the transcriptional
activity of TFIIH. This hypothesis implies that, in tissues
critically affected in TTD, the level of XPD and, by im-
plication, of TFIIH is rate limiting for transcription. Al-
though a recent paper by Satoh and Hanawalt (1997)
has suggested that this is not the case in cell-free extracts
of proliferating human lymphoblastoid cells from XP-D
patients with XP or XP/CS, the situation either in TTD
or in specialized tissues in vivo may be quite different.
A similar effect of gene dosage on clinical features has
recently been reported for two ataxia-telangiectasia fam-
ilies with the same point mutation, 7271GrT, in the
ATM gene (Stankovic et al. 1998). In one family, the
mutation was homozygous, the sensitivity to radiation
was greater, but the clinical features were milder, than
in the second family, in which the mutation was hetero-
zygous. The mutation in the second allele in the second
family resulted in a nonfunctional truncated protein, so
that the patient was functionally hemizygous. These
findings for the ATM gene resemble ours for the XPD
gene.
In conclusion, our findings demonstrate that in TTD
the same mutated allele is associated with a specific UV
hypersensitivity, both in the homozygous patients and
in the functionally hemizygous patients. In contrast, the
severity of the clinical symptoms does not correlate with
the extent of the DNA-repair defect, but it appears to
be influenced by the dosage of the mutated allele. These
findings should stimulate further investigations into the
complex genotype-phenotype relationships of the XPD
gene.
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